MERRF — Myoclonic Epilepsy with Ragged Red Fibers — is a mitochondrial disease caused by point mutations in mitochondrial DNA, most commonly the m.8344A>G mutation in the MT-TK gene encoding mitochondrial transfer RNA for lysine. Like all mitochondrial diseases, MERRF follows maternal inheritance (passed through the mother's egg) and exhibits heteroplasmy, meaning the proportion of mutant to normal mitochondria varies between tissues and between family members, producing a wide spectrum of severity.
Classic MERRF presents with myoclonic seizures (sudden, brief muscle jerks), cerebellar ataxia (coordination problems), progressive muscle weakness, and cardiac conduction defects. In South Africa, diagnosis is available through the NHLS molecular genetics laboratory in Johannesburg, which offers mitochondrial DNA point mutation analysis by request from a neurologist or metabolic specialist.
Healthy mitochondria extract approximately 36 ATP molecules from each glucose molecule through oxidative phosphorylation. In MERRF, defective respiratory chain complex I and IV activity means far fewer ATP are produced per calorie consumed. The body compensates through anaerobic glycolysis, producing excess lactate — which is why MERRF patients experience extreme exercise intolerance and why lactic acid levels are often elevated at rest and spike dangerously with even moderate exertion.
This metabolic impairment creates a cruel irony: the body is simultaneously starving for energy at the cellular level while storing excess calories as fat, because the machinery to burn fat efficiently is itself broken.
The "ragged red fibers" in the name refer to muscle biopsy findings — mitochondria accumulate in clumps at the edges of muscle fibres, visible under modified Gomori trichrome staining. These fibres function poorly. Progressive muscle wasting reduces basal metabolic rate and creates sarcopenic obesity — normal or elevated body weight with disproportionately low muscle mass and elevated fat mass.
MERRF affects the cardiac conduction system, causing heart block, Wolff-Parkinson-White syndrome, and cardiomyopathy in a significant proportion of patients. Cardiac clearance is mandatory before any exercise programme, and maximum heart rate targets must be set in conjunction with a cardiologist.
Several anti-epileptic drugs (AEDs) are both weight-neutral and mitochondrially safer than valproate:
| AED | Weight Effect | Mitochondrial Safety | Notes |
|---|---|---|---|
| Levetiracetam (Keppra) | Neutral | Good | First-line alternative for MERRF myoclonus |
| Clonazepam | Mild gain | Acceptable | Useful for myoclonus; dependence risk long-term |
| Zonisamide | Weight loss | Acceptable | Carbonic anhydrase inhibitor; appetite reduction |
| Topiramate | Weight loss | Caution (mild effect) | Useful add-on; cognitive side effects possible |
| Lamotrigine | Neutral | Good | Not ideal for myoclonus alone; useful combination |
| Phenytoin / Carbamazepine | Neutral/mild gain | Caution | May worsen ataxia in MERRF — use with care |
In South Africa, levetiracetam is available as generic "levetiracetam" and through Keppra brand at most hospital pharmacies. All require specialist prescription and monitoring.
Several nutrients directly support mitochondrial respiratory chain function. While evidence in MERRF specifically is limited to case series and small trials, the theoretical basis is strong and risks are low at recommended doses:
| Nutrient | Role | Dose (adult, consult doctor) | South African Source |
|---|---|---|---|
| Co-enzyme Q10 (CoQ10) | Electron carrier between complexes I/II and III; antioxidant | 300-600 mg/day (ubiquinol form preferred) | Clicks, Dis-Chem, Faithful to Nature |
| Riboflavin (Vitamin B2) | Essential cofactor for complexes I and II | 100-400 mg/day | Any pharmacy; inexpensive |
| L-Carnitine | Shuttles fatty acids into mitochondria for beta-oxidation | 2-3 g/day | Clicks/Dis-Chem supplement aisle |
| Alpha-lipoic acid | Antioxidant; regenerates CoQ10 and Vitamins C/E | 600 mg/day | Health shops, Faithful to Nature online |
| Thiamine (B1) | Cofactor for pyruvate dehydrogenase; reduces lactic acidosis | 50-100 mg/day | Pharmacy, inexpensive |
Ketogenic diets bypass impaired glucose-based ATP production by providing ketone bodies as an alternative fuel. Ketones are metabolised through complex II of the respiratory chain, which is often relatively preserved in MERRF. Several case reports and small series document improved seizure control and reduced lactic acidosis on ketogenic diets in mitochondrial epilepsy.
However, implementing a ketogenic diet in MERRF requires:
In South Africa, the ketogenic diet team at Red Cross War Memorial Children's Hospital in Cape Town has the most experience with paediatric mitochondrial epilepsy. Adult patients may be referred through the neurology department at Groote Schuur or Charlotte Maxeke Johannesburg Academic Hospital.
If a full ketogenic diet is not appropriate, a modified approach still reduces glucose load:
Paradoxically, regular low-intensity aerobic exercise actually improves mitochondrial function over time in mitochondrial disease — it stimulates mitochondrial biogenesis (creation of new mitochondria) and can shift heteroplasmy in muscle tissue toward healthier mitochondria. The key word is low intensity, long term, consistent.
Managing another mitochondrial or neurological condition?
Read our related guides: MELAS Syndrome | Epilepsy and Weight | Myotonic Dystrophy